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Abstract
Hematopoiesis is a complicated and dynamic process about which the molecular mechanisms remain poorly understood.
Danio rerio (zebrafish) is an excellent vertebrate system for studying hematopoiesis and developmental mechanisms. In the
previous study, we isolated and identified a cloche
172 (clo
172) mutant, a novel allele compared to the original cloche (clo)
mutant, through using complementation test and initial mapping. Here, according to whole mount in-situ hybridization, we
report that the endothelial cells in clo
172 mutant embryos, although initially developed, failed to form the functional
vascular system eventually. In addition, further characterization indicates that the clo
172 mutant exhibited weaker defects
instead of completely lost in primitive erythroid cells and definitive hematopoietic cells compared with the clo
s5 mutant. In
contrast, primitive myeloid cells were totally lost in clo
172 mutant. Furthermore, these reappeared definitive myeloid cells
were demonstrated to initiate from the remaining hematopoietic stem cells (HSCs) in clo
172 mutant, confirmed by the
dramatic decrease of lyc in clo
172runx1
w84x double mutant. Collectively, the clo
172 mutant is a weak allele compared to the
clo
s5 mutant, therefore providing a model for studying the early development of hematopoietic and vascular system, as well
as an opportunity to further understand the function of the cloche gene.
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Introduction
Hematopoiesis is a complicated and dynamic process, including
anearlyprimitivewaveand alaterdefinitivewave,whichoccursina
number of anatomic locations and produces all types of blood cells
throughout the lifetime of an animal [1–3]. In vertebrates,
hematopoiesis originates from the ventral mesoderm (VM) and it
has been proposed that the hematopoietic and endothelial cells arise
from a common progenitor, termed hemangioblast [4–6]. In mice,
definitive hematopoiesis is believed to be originated from an intra-
embryonic tissue known as the aorta-gonad-mesonephros with the
presence of the first hematopoietic stem cell (HSC) [2,7,8]. The
HSCs then migrate to the fetal liver, the main hematopoietic organ
during fetal life, and finally home to the bone marrow, where they
undergo further expansion and differentiation into mature blood
cellsshortly after birth [2,8].Despite extensive studies, the molecular
mechanisms of hematopoietic development and the genetic pro-
grams governing the specification, migration and survival of HSCs
in these hematopoietic compartments remain poorly understood.
Danio rerio (zebrafish), a freshwater tropical fish that has features
suitable for N-ethyl-N-nitrosourea (ENU) mutagenesis mediated
large-scale forward genetic screening, is an excellent vertebrate
modelforstudyingdevelopmentalmechanismsofthehematopoietic
and cardiovascular system [9–12]. Moreover, the hematopoietic
program is highly conserved between zebrafish and mammals
[13,14], so the study of zebrafish hematopoiesis and vascular system
development would also contribute to our understanding of this
process in higher organisms.
The formation of vertebrate blood vessel can be subdivided into
two distinct processes, vasculogenesis and angiogenesis [15]. In
vertebrates, the differentiation of the hemangioblasts from the
mesoderm and their subsequent migration to form the main axial
vessels, which will then undergo lumen formation and artery-vein
differentiation, is named "vasculogenesis" [16]. After vasculogen-
esis, the following sprouting and growth of new vessels from the
pre-existing vessels named angiogenesis [17]. Zebrafish vascular
system originates from the formation of bi-potential cells –
hemangioblast from the ventral mesoderm (VM) at 6 hpf in
gastrulation stage [18]. By 12 hpf these cells migrate to lateral
plate mesoderm (LPM) where they differentiate to angioblast [18].
By 16 hpf, these angioblasts in LPM converge in the midline of
vascular cord located between dorsal ectoderm and notochord
[18]. By 28–30 hpf, the dorsal aorta (DA) and the posterior
cardinal vein (PCV) can be discerned and are fully lumenized [19].
Similarly to mammals, zebrafish hematopoiesis also consists of
primitive and definitive programs, and generates differentiated
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mammals [20]. Zebrafish primitive erythropoiesis originates from
the posterior lateral mesoderm (PLM) as a pair of bilateral stripes
at 5-somite stage [11]. These stripes subsequently extend ante-
riorly and posteriorly, and converge in the midline at 20-somite
stage to form the main structure of the intermediate cell mass
(ICM) where the erythroid progenitors further proliferate and
differentiate, enter blood circulation, and finally mature at around
5–7 days post fertilization (dpf) [21]. Zebrafish primitive
myelopoiesis arises from the anterior lateral mesoderm (ALM) at
10-somite stage and produces mainly macrophages and neutro-
phils [22,23]. Zebrafish definitive hematopoiesis is believed to
initiate from the ventral wall of dorsal aorta (VDA), an equivalence
of the mouse aorta-gonads-mesonephros (AGM), with the
formation of HSCs from the hemogenic endothelial cells at 26-
30 hours postfertilization (hpf) [24,25]. By 2 dpf, these HSCs in
the ventral wall of DA migrate to the posterior blood island (PBI)
(also referred to as caudal hematopietic tissue, CHT) [26] located
between caudal artery and caudal vein, and finally home to
kidney, the adult hematopoietic organ in zebrafish, by 5 dpf
[27,28].
In the previous study [29], we have isolated a differentiated
myeloid lineage marker lysozyme C (lyC) -deficient mutant by
whole-mount in situ hybridization (WISH), cloche
172 (clo
172), which
was further confirmed as a new cloche mutant allele by com-
plementation tests and positional cloning experiments [29]. The
zebrafish cloche (clo) mutant, named for its bell-shaped heart, carries
a spontaneous mutation characterized by severe deficiency in
endothelial and blood cells, as well as the endocardium[30]. clo
acts upstream of the genes important for hematopoietic and
vascular development in zebrafish, including stem cell leukemia
hematopoietic transcription factor (scl), the homeobox gene (hhex),
GATA binding protein 1 (gata1), fetal liver kinase 1 (flk1), friend
leukemia integration 1 (fli1) and ETS1-related protein (etsrp)
[13,31–34]. In addition, the defects in clo during vascular deve-
lopment are cell-autonomous, whereas those in blood cell develop-
ment are both cell- and non-cell-autonomous [35]. All of these
studies indicate that clo affects hematopoietic and endothelial cell
development at a very early stage, which may be at the level of the
hemangioblast. Unfortunately, the exact gene responsible for the
clo mutant remains unknown owing to its telomeric location on
chromosome 13 [31,32]. A recent study showed that lysocardio-
lipin acyltransferase (lycat) mRNA partially rescue the blood
lineage in clo mutants [32]. Although lycat is the earliest known
player in the generation of both endothelial and hematopoietic
lineages [32], direct evidence suggesting that lycat is responsible for
the clo hematopoietic phenotype is still lacking.
Here we report that, by further characterization of both vas-
cular and hematopoietic development in clo
172,t h eclo
172 mutant
is a weak allele of the clo mutant, showing varying degrees of
developmental defects in endothelial and hematopoietic cells, especially
in the myeloid lineage cells. The vascular cells in clo
172 mutant were
initially developed but failed to form the final functional vessels. For
hematopoietic development, the primitive erythroid cells were less
affected compared to the primitive myeloid cells which were totally lost
inclo
172. However, the definitive hematopoiesis including erythroid and
myeloid cells reappeared to some extent in clo
172 mutant. Combined
with the examination of hematopoietic stem cell marker c-myb
expression, we speculate that definitive hematopoietic cells are derived
from the remaining HSCs in clo
172 mutant. Consistent with our
hypothesis, the lyc-positive myeloid cells were greatly reduced in 3 dpf
clo
172runx1
w84x double mutant compared with that in the clo
172 mutant,
confirming the definitive origin of those hematopoietic cells. In
summary, the clo
172 mutant, carrying a novel allele compared to the
clo
s5 mutant, presents a weak endothelial and hematopoietic
phenotype. The clo
172 mutant not only provides a model for studying
early development of primitive and definitive hematopoietic cells, but
also an opportunity to further understand the function of the clo gene.
Results
The vascular development in clo
172 mutant embryos is
partially defective
The zebrafish clo mutant is notable as its defects in both endothelial
and blood cells at a very early stage. Therefore, we firstly explored the
development of vascular system in clo
172. Flk1, am e m b e ro ft h e
vascular endothelial growth factor (VEGF), was utilized to perform
the whole mount in-situ hybridization to characterize the develop-
ment of endothelial cells and their progenitors in clo
172 mutant. The
flk1
+ cells were found in the trunk region in clo
172 up to 19.5 hpf,
which called the DA and PCV later stage, although its expression
level was lower than that in siblings (Figure 1A, B). In 1 dpf wild
type embryos, the endothelial cells were present in the head, DA,
PCV and intersegmental vessels (ISV) (Figure 1D). In clo
172 mutant
embryos, the anterior of head, DA and PCV were clearly expressing
flk1 but broken in line (Figure 1E), which indicated that endothelial
cells were formed in situ but unable to connect into a tube. In 2 dpf
wild type embryos, the dorsal longitudinal anastomotic vessels
(DLAV) also expressed flk1 (Figure 1G). The flk1
+ cells in 2 dpf
clo
172 mutant embryos were faintly stained in ISV and DLAV
(Figure 1H), whichsuggestedthatvascularsystemdevelopmentwas
affected in the clo
172 mutant embryos. In clo
s5 mutant embryos,
however, the expression of flk1was completely absent except in lower
trunk and tail region (Figure 1C, F, I). The temporal and spatial
expression pattern of flk1 in clo
172 m u t a n te m b r y o ss u g g e s t st h a t
vasculogenesis, the de novo formation of vessel, is initiated but the
subsequent connection is blocked, which may be related to the lumen
formation and later remodeling process.
clo
172 mutant shows severe defects in primitive
myelopoiesis but partial defects in erythopoiesis
To uncover the difference of hematopoietic process between clo
s5
and clo
172 mutant,we first characterized the development of primitive
blood cells in clo
172 mutant at different developmental stages. The
temporal and spatial expression of the erythroid lineage marker be1
was observed in the posterior lateral mesoderm (PLM) as two stripes
at the 14 hpf stage (Figure 2A) and then merged to form the
intermediatecellmass(ICM)at1 dpf(Figure2D),aswellasinVDA
region at 36 hpf (Figure 2G). Expression of be1 in clo
172 mutant
embryoswaspartiallydecreased atcorrespondingstages(Figure2B,
E, H) but significantlylost in clo
s5 mutant embryos (Figure2C,F,I).
The different be1 expression between the mutants indicates that
primitive erythropoiesis in clo
172 mutant is partially defective but not
completely disrupted as that in clo
s5 mutant.
The differentiated myeloid lineage markers l-plastin (Figure 3)
and lyC (Figure S2) were utilized to detect the primitive mye-
lopoiesisinclo
172 mutant embryos[36,37].In the sibling embryos,up
to19.5 hpf,the primitive myeloidcells reside inthe anterior cephalic
mesoderm (Figure 3A, Figure S2A). As embryos develop, myeloid
cells migrate onto yolk sac syncitial layer and colonize the posterior
partoftail at 1 dpf (Figure3D, Figure S2D), andfurther appear in
VDA region at 36 hpf (Figure 3G). Largely in accordance with clo
s5
mutants (Figure 3C, F, I, Figure S2 C, F), the l-plastin
+ and lyC
+
myeloid cells were undetectable in clo
172 mutants at 19.5 hpf and
1d p f( Figure 3B, E, Figure S2 B, E) compared to that in the same
stages of siblings, whereas rare cells were observed in the tail region
at 36 hpf clo
172 mutants (Figure 3H).
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severelyaffectedasthatofmyeloidcellsintheclo
172mutantembryos
during primitive hematopoiesis, in contrast to the seriously defective
development of both lineages in the clo
s5 mutant.
Myeloid lineage is partially recovered in clo
172 mutants
during Definitive hematopoiesis
Our previous study [29] has showed that the red blood cells
were present in VDA region in clo
172 mutant at 2 dpf (Figure S1),
we therefore performed the WISH experiment to further examine
the development of definitive hematopoiesis in clo
172 mutant. Since
all the hematopoietic cells are arisen from a common ancestor
known as hematopoietic stem cells (HSCs), we firstly investigated
the development of HSCs in clo
172 mutant. In zebrafish definitive
hematopoiesis, c-myb was characterized as the stem cell marker
with its presence in the VDA at around 36 hpf[24,38]. In sibling
embryos, c-myb
+ cells are arranged in a line along the VDA at
36 hpf (Figure 4A) and assembled in tail region named as PBI at
3 dpf (Figure4 D). WISH indicated that the expression of HSC
marker c-myb decreased greatly at 36 hpf and slightly at 3 dpf
stage in clo
172 mutant embryos(Figure 4B, E). In contrast, the
expression of cmyb was completely lost in clo
s5 mutant embryos
(Figure 4C, F). These data indicated that HSCs are present but
reduced in clo
172 mutant when compared to wild type embryos.
Figure 2. Dynamic be1 expression during primitive hematopoiesis in clo
172 and clo
s5 mutant embryos. (A–I) Whole-mount in situ
hybridization of be1 expression in sibling embryos at 14 hpf (A), 1 dpf (D) and 36 hpf (G), and clo
172 mutant embryos at 14 hpf (B), 1 dpf (E) and
36 hpf (H), and clo
s5 mutant embryos at 14 hpf (C), 1 dpf (F) and 36 hpf (I). Embryos are shown with anterior to the left and dorsal up. PLM: posterior
lateral mesoderm; ALM: anterior lateral mesoderm; ICM: intermediate cell mass; VDA: ventral wall of dorsa aorta.
doi:10.1371/journal.pone.0027540.g002
Figure 1. Expression of flk1 in clo
172 and clo
s5 mutants. (A–I) Whole-mount in situ hybridization of flk1 expression at 19.5 hpf in sibling (A),
clo
172 mutant (B) and clo
s5 mutant (C) embryos, 1 dpf stage in sibling (D), clo
172 mutant (E) and clo
s5 mutant (F) embryos, and 2 dpf stage in sibling
(G), clo
172 mutant (H) and clo
s5 mutant (I) embryos. Embryos are shown with anterior to the left and dorsal up. Inserts are high magnification (206)o f
the corresponding boxed regions. DA: dorsa aorta; PCV: posterior cardinal vein; DLAV: dorsal longitudinal anastomotic vessels.
doi:10.1371/journal.pone.0027540.g001
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172 and clo
s5 mutant embryos. (A–I) Myeloid lineage marker l-plastin expression at 19.5 hpf(A: the left
arrow show anterior cephalic mesoderm, B–C), 1 dpf stage (D: the left arrow show anterior cephalic mesoderm, E–F), and 36 hpf stage (G: the left
arrow show anterior cephalic mesoderm H–I) in sibling, clo
172 and clo
s5 mutant embryos. Embryos are shown with anterior to the left and dorsal up.
Inserts are high magnification (206) of the corresponding boxed region (the right arrow show tail region).
doi:10.1371/journal.pone.0027540.g003
Figure 4. Definitive hematopoiesis in clo
172 and clo
s5 mutant embryos. (A–C) stem cell marker c-myb expression at 36 hpf and 3 dpf stage in
wild type (A: arrow show VDA region; D: arrow show PBI region), clo
172 (B, E) and clo
s5 mutant (C, F) embryos.(G–I). WISH of be1 expression at 4 dpf
stage in sibling (G: arrow show PBI region), clo
172 (H) and clo mutant (I) embryos. (J–L) WISH to detect l-plastin expression at 4 dpf stage in sibling (J:
arrow show PBI region), clo
172 (K) and clo
s5 mutant (L) embryos. (M–O)WISH of T lymophcyte marker rag1 expression at 4 dpf stage in sibling (M:
arrow show thymus), clo
172 (N) and clo
s5 mutant (O) embryos. Embryos are shown with anterior to the left and dorsal up. Inserts are high
magnification (206) of the corresponding boxed regions. VDA: ventral wall of dorsa aorta; PBI: posterior blood island.
doi:10.1371/journal.pone.0027540.g004
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172
mutant embryos.
To examine our speculation, we further characterized clo
172
mutants to determine the development of definitive hematopoietic
cells that derived from the HSCs. As show in figure 4 and figure S3,
in wild type embryos, the expression of be1
+ (red blood cell marker),
l-plastin
+ and lyc
+ cells (myeloid cell marker) were normally localized
in PBI region at 3 and 4 dpf stage (Figure 4G, J, Figure S3 A, D).
No obvious differences in be1 expression were observed between
clo
172 mutants and siblings, except that red blood cells located in the
VDA region (Figure 4H) at 4 dpf, which may be due to the lack of
blood circulation in the clo
172 mutants. In contrast, be1
+ cells were
nearly undetectable in the clo
s5 mutant (Figure 4I). On the other
hand, the examination of the expression of myeloid lineage markers
l-plastin and lyc indicated that myeloid cells were decreased but
ectopicallyexpressedina gradient manner inVDAinclo
172mutants
at 3 dpf and 4 dpf (Figure 4K, Figure S3 B, E) compared with
wild-type siblings, whereas they were also undetected in the clo
s5
mutant at 3 dpf (Figure 4L, Figure S3 C, F). Furthermore,
investigation of the T-lymphocyte developmental marker rag1
revealed that it was totally lost in thymus in both clo
172 and clo
s5
mutants at 4 and 5 dpf (Figure 4N, O, Figure S3 H, I). These
data reveal that definitive erythropoiesis and myelopoiesis, but not
lymphocyte, are more or less defective in the clo
172 mutant embryos.
Additionally, the development of the definitive myeloid lineage was
obviously different from its primitive counterpart.
Taken together, the results suggest that hematopoietic cells
partially develop in the clo
172 mutant during definitive hematopoi-
esis, which shows a weak phenotype compared to the clo
s5 mutant.
Definitive myeloid lineage cells in clo
172 mutant
originated from the remaining HSCs population
Since the HSCs were partially formed in the clo
172 mutant, we
therefore continued to exam whether the presented definitive myeloid
cells were differentiated from the remaining HSCs. Thus, we
introduced runx1mutation, the well-known gene required for the
definitive hematopoiesis in zebrafish[39,40], into the clo
172 mutant
background by crossing clo
172 (+/-) mutant with runx1
w84x mutant[41],
and then examined the development of definitive myeloid cells in their
offspring. The embryos showing clo
172 mutant morphology change (no
circulation, edema of heart) were firstly selected and fixed at 3 dpf,
a n da p p l i e dt oW I S Ht od e t e c tlyc.T h en u m b e ro flyc
+ cells was
counted and each fish was genotyped for runx1 mutation. The results
showed that lyc
+ cells were dramatically decreased in PBI region of
Figure 5. Analysis of the origin of definitive myeloid cells in clo
172 mutant. (A, B) lyc expression pattern at 3 dpf runx1/clo
172 double
mutant (A). WISH of lyc expression in siblings (A–i), clo
172 mutant (A–ii), clo
172 (-/-) runx1 (+/-)
w84x (A-iii), double homozygous mutant (A–iv). Histogram
of lyc
+ cells number (means) in siblings(B, purple column), clo
172 mutant (B, green column), clo
172 (-/-) runx1 (+/-)
w84x (B, pink column) and double
homozygous mutant (B, blue column). There are significant differences between double mutant and other groups (*p,0.05), but no difference
between clo
172 mutant and clo
172 (-/-) runx1 (+/-)
w84x group (p.0.05). The corresponding case numbers were shown by n in column.
doi:10.1371/journal.pone.0027540.g005
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172(-/-)runx1
w84x (-/-)embryos compared to that in clo
172(-/-) em-
bryos at 3 dpf stage (Figure 5A-ii, iii, iv)( Figure 5A-i). Remark-
ably, the statistic analysis by ANOVA statistic method showed that
there were significant differences (p,0.05)in lyc
+ cell number among
clo
172(-/-)runx1
w84x (-/-)group (case number=16), clo
172(-/-)runx1
w84x
(+/-)(case number=58) group, clo
172(-/-) group (case number=34),
and siblings (case number=16) (Figure 5B) and there was no
significant differences (p.0.05)between clo
172 (-/-) runx1
w84x
(+/-)group and clo
172(-/-) group. Thus, our data suggest the definitive
origin of the presented myeloid cells in 3 dpf clo
172 mutant, which were
derived from the remaining HSCs in the clo
172 mutant through a
runx1-dependent manner.
Discussion
The clo
172 mutant embryos are identified by a lack of blood
circulation but no obvious morphological changes (Figure S1B)
before 30 hpf. Similar to clo
s5 mutants, clo
172 mutants gradually
exhibit slight swelling of the heart and morphological changes
from 2 dpf onward and thereafter (Figure S1E, F). Although the
morphological changes are similar to those in clo
s5 mutants, the red
blood cells are clearly visible and localized in the VDA region of
clo
172 mutants (Figure S1E). These data (detailed description in
Materials S1) suggested that the clo
172 mutant was a different allele
compared to the clo
s5 mutant. Thus, the clo
172 mutant was used for
further characterization of vasculogenesis and hematopoiesis, and
the results were compared to those from clo
s5 mutants to identify
differences between these two mutants.
WISH of flk1 in clo
172 mutants revealed that vascular endo-
thelium cells were able to form in situ but unable to connect into
tubes. We predict that vascular system development is normally
initiated but finally fails to form the functional vascular system,
which may be defective in lumen formation and later remodeling
process.
Unlike clo
s5 mutants, in which the development of all lineages in
hematopoiesis is severely defective, the clo
172 mutant shows partial
defects in both primitive and definitive erythropoiesis. By contrast,
myelopoiesis is more complicated in the clo
172 mutant. An
interesting issue raised by this study is that the development of
primitive myeloid cells is seriously affected, whereas the definitive
myelopoiesis is partially restored in the clo
172 mutant. According to
the expression of HSC marker c-myb, we observed dramatically
decreased but still retained c-myb
+ cells in the clo
172 mutant during
definitive hematopoiesis. Due to the remainig HSCs present in
the clo
172 mutant, we predicted that definitive erythroid and
reappeared myeloid cells might originate from them. Based on
Nancy A. Speck’s report[39], which noted that runx1 was required
for the emergence of hematopoietic stem cells (HSCs) from
hemogenic endothelium during embryogenesis, we speculated that
lyc
+ cells in the 3 dpf clo
172 mutant would greatly decreased in PBI
region due to the loss of runx1 gene. To validate our speculation,
we crossed the runx1
w84x mutant with clo
172 mutant and examined
the expression of lyc in their offspring. The results showed that lyc
+
myeloid cells were dramatically reduced in PBI region at 3 dpf
stage in runx1
w84xclo
172 double mutant, therefore confirming their
definitive origin through the runx1 dependent manner. In addition,
it is notable that the blood cell migration is probably dependent on
blood flow [42]. Hence, we speculate that visible red blood cells
and reappeared myeloid cells existing in the VDA region in the
clo
172 mutant might be caused by the lack of blood circulation.
Our study has provided evidence that the clo
172 mutant is a
weak allele compared to the clo
s5 mutant with partially developed
primitive and definitive hematopoiesis, thus providing a model for
studying the early development of hematopoietic and vascular
system, as well as an opportunity to further investigate the function
of clo gene in genetic pathways.
Materials and Methods
Ethics statement
All experimental protocols and animals used in this research
were approved by Ethical Committee of Southern medical Uni-
versity (LS2011–030).
Zebrafish husbandry
Zebrafish were raised and handled as previously described
[43,44]. The cloche
s5 mutant used in this study was kindly provided
by Dr. Didier Y.R. Stainier’s laboratory (University of California
at San Francisco). The runx1
w84x mutant [41] was used to cross
with clo
172 (+/-) to generate clo
172 (+/-) runx1
w84x (+/-).
In vitro synthesis of antisense RNA probes
Antisense RNA probes were prepared by in vitro transcription
according to a standard protocol [43]. The following probes were
used in the study: digoxigenin (DIG)-labeled antisense be1-globin,
lyC, l-plastin, rag-1, c-myb, runx1 and flk1.
Whole-mount in situ hybridization
Embryos at different stages were used to examine hematopoi-
etic-related gene expression by WISH as previously described[43].
Consistent with the Mendelian law of heredity, the ratio of mutant
to total embryos was approximately 1/4 (Table 1).
Genotyping of runx1 gene
The clo
172 (-/-) embryos were picked out from clo
172 (+/-)
runx1
w84x (+/-) offspring based on the phenotype of no circulation
Table 1. No. of embryos used in WISH.
Probe Stage of embryos
clo
172 mutant
(mutant/total)
clo
s5 mutant
(mutant/total)
flk1 21 s 39/156 31/133
flk1 1 dpf 28/117 24/102
flk1 2 dpf 25/104 23/97
be1 14 hpf 52/219 54/221
be1 1 dpf 37/156 35/149
be1 36 hpf 58/208 54/200
be1 4 dpf 34/132 38/145
l-plastin 19.5 hpf 23/94 29/123
l-plastin 1 dpf 39/152 41/163
l-plastin 36 hpf 53/206 49/197
l-plastin 3 dpf 41/171 38/154
l-plastin 4 dpf 37/152 33/149
c-myb 36 hpf 37/152 34/147
c-myb 3 dpf 27/116 31/127
Rag-1 4 dpf 22/93 25/103
rag1 5 dpf 48/189 44/181
lyC 19.5 hpf 36/159 40/165
lyC 1 dpf 43/165 41/162
lyC 3 dpf 53/209 49/201
M: No. of mutant embryos; T: No. of total embryos.
doi:10.1371/journal.pone.0027540.t001
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PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27540at 28 hpf. Then these embryos were used to check the level of lyc
by WISH. After washing with PBST, the genomic DNA was
extracted from each embryo for the PCR amplification using runx1
primers followed: 59-TGGTGGGCAAACTGCGCATG-39 and
59-TTCTTGCTGTGACACTGAGC-39. Subsequently, the ge-
notype of sibling versus mutants was easily distinguished by the
different size of the PCR product after digestion by the Hae II
enzyme.
Supporting Information
Figure S1 Dynamic morphological changes of clo
172 and
clo
s5 mutant. (A–F) Lateral view of morphological changes
30 hpf stage of sibling (A), clo
172 (B), clo
s5 mutant (C) and 2 dpf
stage of sibling (D), clo
172 (E: arrow show edema heart and red
blood cell in VDA region), clo
s5 mutant (F: arrow show edema
heart).
(TIF)
Figure S2 Expression of lyc during primitive hemato-
poiesis in clo
172 and clo
s5 mutant embryos. (A–F) Whole-
mount in situ hybridization of lyc expression at 19.5 hpf (A: arrow
show anterior cephalic mesoderm, B–C), 1 dpf stage (D: the left
arrow show anterior cephalic mesoderm, E–F) in sibling, clo
172
mutant and clo
s5 mutant embryos. Embryos are shown with
anterior to the left and dorsal up. Inserts are high magnification
(206) of the corresponding boxed regions.
(TIF)
Figure S3 Definitive myelopoiesis and rag1 expression
pattern in clo
172 and clo
s5 mutant embryos. l-plastin and lyc
expression at 3 dpf in sibling(A, D), clo
172 (B, E), clo
s5 mutant (C,
F). rag1 expression at 5 dpf in sibling(G), clo
172 (H), clo
s5 mutant
(I). Inserts are high magnification (206) of the corresponding
boxed regions (the right arrow show tail region).
(TIF)
Materials S1 Supporting materials.
(DOC)
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